Arecor Therapeutics plc announced that Susan Lowther has decided to step down from her role as Chief Financial Officer to pursue new opportunities. A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July 2024, to ensure an effective handover.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 GBX | 0.00% | -19.81% | -30.14% |
06-10 | Political turmoil hits euro and banks | AN |
06-10 | Europe heads lower amid political turmoil in EU | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.14% | 49.68M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Chief Financial Officer, Effective from July 22, 2024